Effects of (±)-huprine Y and (±)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors

M. M. Alcalá, A. Maderuelo, N. M. Vivas, P. Camps, D. Muñoz-Torrero, M. V. Clos, A. Badia

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


The cholinergic profile of (±)-huprine Y and (±)-huprine Z on muscarinic receptors has been determined. Displacement of [3H]- pirenzepine and [3H]-QNB plus pirenzepine was performed in rat hippocampus. Both compounds showed a higher degree of affinity to M1 muscarinic receptors (P < 0.01) than to M2 muscarinic receptors. To determine the M1 agonist or antagonist role of the two huprines, studies of inositol phosphates (IP) production were performed. Both huprines significantly stimulated IP accumulation in a concentration-dependent manner. The reversion of this effect by different antagonists showed that M1 muscarinic receptors were activated by (±)-huprine Y and (±)-huprine Z, but some other mechanisms, such as α1- adrenoceptors or nicotinic receptors, were involved. © 2004 Elsevier Ireland Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)106-109
JournalNeuroscience Letters
Publication statusPublished - 6 May 2005


  • (±)-Huprine Y
  • (±)-Huprine Z
  • AChE inhibitor
  • Alzheimer's disease
  • Huperzine A
  • Muscarinic receptors
  • Tacrine


Dive into the research topics of 'Effects of (±)-huprine Y and (±)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors'. Together they form a unique fingerprint.

Cite this